Vimian Group AB (publ) Q2 2025 Earnings | 07/18/2025
Vimian Group AB (publ) reported its Q2 2025 results on July 18, 2025, showcasing double-digit revenue growth, a resilient performance across its core business segments, and continued execution on its strategy as a global animal health leader. Total revenue for the second quarter increased by 15% year-over-year to EUR 104.3 million, with organic growth of 5%. Growth was broad-based, though the MedTech segment experienced a 4% organic decline attributed to ongoing softness in the US surgery market. Adjusted EBITA rose by 3% to EUR 25.4 million, representing an adjusted EBITA margin of 24.4%, al…